Micron Technology, Inc. (NASDAQ:MU – Get Free Report) was the target of unusually large options trading on Monday. Stock investors purchased 259,705 call options on the company. This is an increase of ...
Soligenix begins confirmatory phase 3 trial of HyBryte for treatment of cutaneous T-cell lymphoma: Princeton, New Jersey Wednesday, December 18, 2024, 14:00 Hrs [IST] Soligenix, I ...
Malawi’s ambition to embrace digitalization continues to face setbacks, with the registration and licensing process for teachers highlighting significant obstacles. The initiative, spearheaded by the ...